SCNI

#5160
Scinai Immunotherapeutics Ltd. American Depositary Shares
0.6021 USD
+1.81%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
0.6021
0.6021
Intervallo Annuale
0.5500
1.0499
Variazione giornaliera
+1.81%
Variazione Mensile
-15.32%
Variazione di 6 mesi
-20.38%
Variazione Annuale
-20.38%
Chiusura Precedente
0.5914
Apertura
0.6021
Bid
Ask
Minimo
0.6021
High
0.6021
Volume
1
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 2.0882 M
  • Employee 31
  • Founded 2003
  • CEO N/A
  • Website www.scinai.com
  • Headquarter Israel
  • FIGI BBG007TGL1R2
  • Industry Technology
Ricavi totali
Utile netto
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti

Scinai Immunotherapeutics Ltd - American Depositary Shares

BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases. In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis.

Notizie